Disparities in Myocardial Infarction Remodeling According to Gender

The primary outcome measure will be the occurrence of left ventricular remodeling (defined as a change in ventricular volume of more than 10% during follow-up) measured with cardiac imaging (echocardiography and MRI)

Changes in ventricular volumes between acute phase and 3 months measured with cardiac imaging (echocardiography and MRI)

Changes in ventricular volumes between acute phase and 1 year measured with cardiac imaging (echocardiography and MRI)

renal function: uremia and creatinine levels, combined with an assessment of the protein-to-creatinine ratio in urine samples, and a cyto-bacteriological examination of urine to detect hematuria; hepatic function: The Fibroscan® is a device that enables a non-invasive and efficient assessment of liver fibrosis and steatosis within minutes at the patient's bedside, providing an immediate result displayed on the device screen; peripheral artery disease: Doppler echocardiography of the supra-aortic trunks; way of life : dietetary, stress and physical activity scores common CV risk factors: prior history of hypertension, hypercholesterolaemia, tobacco use, diabetes

Occurrence of complications and cardiovascular events (cardiovascular death, heart failure, stroke, or reinfarction)

Anxiety/Depression (A.D) score: 2 scales from 0 to 21, the greatest the more prone to either anxiety or depression

Mediteranean diet score (MED): from 0 to 14, the greatest the more relevant for mediteranean diet

physical activity: lipid research clinics (LRC); 2 scales from 1 to 5, the greatest the less active

presence or absence of endometriosis

presence or absence of polycystic ovary

presence or absence of uterine fibroma

presence or absence of hormonal therapy

date of first period

number of pregnancy

number of children

absence or presence of obstetrical events (hypertension, diabete, microsomia and macrosomia)

absence or presence of menopause